First Complete Remission versus other- than- First Complete Remission in Acute Myelogenous Leukemia with Allogeneic Hematopoietic Stem Cell Transplantation

First Complete Remission versus other- than- First Complete Remission in Acute Myelogenous Leukemia with Allogeneic Hematopoietic Stem Cell Transplantation

Show other versions (1)

Introduction: The traditional goal of the treatment of Acute Myelogenous Leukemia is to produce and maintain a complete remission (CR).The difference in survival time was entirely attributable to the duration of time spent in CR .In this study, the outcome of AML patients with allogeneic HSCT in CR1...

Full description

Bibliographic Details
Main Authors: Ardeshir Ghavamzadeh, Atefeh Masnavi, Farnaz Khatami, Arash Jalali, Mohammad Jahani, Masoud Iravani, Seyed Asad-o-allah Mousavi, Babak Bahar
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2009-06-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Hematopoietic Stem Cell Transplantation
Acute Myelogenous Leukemia
Allogeneic
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/207

Internet

https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/207

Similar Items